Challenges with Structuring Technology and Life Science Deals

Very pleased to participate in this LES panel for a robust discussion of on the common challenges and hurdles that emerge when negotiating and executing IP based deals across technology and life sciences. Topics discussed included bridging valuation gaps, what’s critical to address in early term sheets/discussions to avoid lengthy renegotiations and negotiation strategies.